FANCB Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">FANCB Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>FANCB</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Fanconi Anemia Group B</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xq22.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>63027</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>300515</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000128590</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8TD96</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Fanconi anemia core complex</td>
</tr>
<tr>
<td class="label">Length</td>
<td>859 amino acids</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">DNA repair</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
FANCB (Fanconi Anemia Group B) encodes a critical component of the Fanconi anemia (FA) core complex, a multisubunit protein assembly essential for the FA DNA damage response pathway. Unlike most FA genes that are autosomal, FANCB is located on the X chromosome (Xq22.3), making it unique in the FA family. In males, a single mutation (hemizygous) results in complete loss of FANCB function, causing severe Fanconi anemia with early onset of bone marrow failure and developmental abnormalities[@huang2018]. The FA pathway is crucial for resolving DNA interstrand crosslinks (ICLs), which are among the most cytotoxic forms of DNA damage. Beyond its well-established role in FA, emerging evidence suggests that FANCB and the FA pathway contribute to neuronal survival and may be relevant to neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.
Molecular Function
FA Core Complex
The FA core complex is a multisubunit assembly comprising at least nine proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM, and FAAP20). This complex serves as the "hub" of the FA pathway:
Core Complex Assembly:
- FANCB acts as a scaffold, binding directly to FANCA, FANCC, and FANCL
- FANCL contains the E3 ubiquitin ligase activity essential for downstream activation
- FANCM provides DNA binding capacity, anchoring the complex to ICL sites
- FAAP20 stabilizes the complex and connects to the Fanconi anemia-associated proteins
DNA Interstrand Crosslink Repair
FANCB participates in the central mechanism of ICL repair:
Damage detection: DNA ICLs block DNA replication and transcription
Core complex recruitment: FANCB helps assemble the FA core at damage sites
FANCD2 activation: The core complex monoubiquitinates FANCD2
downstream repair: Monoubiquitinated FANCD2 coordinates DNA repair proteins
Resolution: Completed repair allows DNA replication to proceedThe ICL repair process involves multiple DNA repair pathways including:
- Nucleotide excision repair (NER)
- Homologous recombination (HR)
- Translesion synthesis (TLS)
- Fanconi anemia-specific factors
Structural Features
FANCB contains:
- N-terminal region: Protein interaction domains
- C-terminal region: Required for complex assembly
- Multiple protein-binding interfaces: Connects to FANCA, FANCC, FANCL
Role in Neurodegeneration
DNA Damage and Neuronal Death
Neurons are particularly vulnerable to DNA damage due to their post-mitotic state and high metabolic activity. The FA pathway may protect neurons:
- Oxidative stress: Neurons accumulate oxidative DNA damage
- Repair capacity: The FA pathway contributes to DNA repair in neurons
- Aging: Age-related decline in FA pathway function may contribute to neurodegeneration
Alzheimer's Disease
FANCB involvement in AD:
Genomic instability: Increased DNA damage in AD brain
FA pathway dysregulation: Altered FANCB expression in AD
Oxidative stress: ROS-induced DNA damage in AD
Neuronal vulnerability: Impaired DNA repair contributes to neuron lossParkinson's Disease
In PD, FANCB may be relevant through:
- Dopaminergic neuron sensitivity: High oxidative stress in substantia nigra
- Mitochondrial DNA damage: mtDNA lesions in PD
- Aging: Age-related decline in DNA repair capacity
- FANCD2 activation: Altered FA pathway in PD models
Amyotrophic Lateral Sclerosis (ALS)
FANCB in ALS:
- DNA repair defects: Impaired DNA repair in ALS
- Motor neuron vulnerability: High metabolic demand increases DNA damage
- FA pathway alterations: Changed expression in ALS models
Fanconi Anemia
Clinical Features
FANCB mutations cause X-linked Fanconi anemia, characterized by:
- Bone marrow failure: Pancytopenia, often severe in childhood
- Congenital anomalies: Radial ray defects, short stature, characteristic facial features
- Cancer predisposition: High risk of acute myeloid leukemia, solid tumors
- VACTERL association: Vertebral, anal, cardiac, tracheal, esophageal, renal, limb anomalies
- Growth and developmental delays: Multiple systems affected
Genetics
FANCB inheritance pattern:
- X-linked recessive: Only males affected (hemizygous)
- Carrier females: Usually asymptomatic carriers
- De novo mutations: Common, no family history
- Variant severity: Null alleles most severe
Diagnosis
- Genetic testing: FANCB sequencing confirms diagnosis
- Chromosomal breakage test: Sensitivity to diepoxybutane (DEB) or mitomycin C
- Fanconi anemia pathway analysis: FANCD2 monoubiquitination assay
Expression Patterns
Tissue Distribution
FANCB is ubiquitously expressed:
- Highest: Testis, bone marrow, thymus
- Moderate: Most tissues including brain
- Low: Some peripheral tissues
Cellular Expression
- Proliferating cells: Highest expression in dividing cells
- Neurons: Lower but detectable expression
- Glial cells: Expressed in astrocytes and microglia
Developmental Regulation
- Embryonic: Expression throughout development
- Adult: Maintained in most tissues
- Cell cycle: Upregulated during S phase
Therapeutic Approaches
Fanconi Anemia
Current and emerging treatments:
Androgen therapy: Historical treatment for bone marrow failure
Hematopoietic stem cell transplantation: Curative for bone marrow failure
Gene therapy: Experimental approaches to restore FANCB function
Small molecule approaches: Enhancing FA pathway functionNeurodegeneration
Potential applications for neurodegenerative diseases:
DNA repair enhancement: Small molecules that boost FA pathway
Antioxidant approaches: Reduce oxidative DNA damage
Gene therapy: For specific neurological applicationsCancer Prevention
FA pathway in cancer:
- Chemotherapy sensitivity: FA-deficient cells sensitive to crosslinking agents
- Therapeutic targeting: Cancer-selective therapies based on FA status
FA Pathway Overview
Core Complex Activation
The FA pathway is triggered by DNA ICLs:
Sensor: FANCM detects ICLs and recruits the core complex
Assembly: Core complex (including FANCB) assembles at damage sites
Activation: FANCL E3 ligase monoubiquitinates FANCD2
Effector: FANCD2 recruits repair proteins to DNA
Resolution: DNA repair completes, pathway resetsDownstream Effectors
After FANCD2 activation:
- BRCA1/2: Homologous recombination proteins
- RAD51: Strand invasion and repair
- SLX4: Endonuclease complex
- ATR/Chk1: Cell cycle checkpoint
Cross-Talk with Other Pathways
- BRCA network: FA and BRCA pathways intersect
- NER pathway: Core ICL repair machinery
- Cell cycle control: Checkpoint coordination
Clinical Relevance
Genetic Testing
- Diagnostic testing: For suspected FA patients
- Carrier testing: For female relatives of FANCB patients
- Prenatal diagnosis: For families with known mutations
Biomarkers
- FANCD2 monoubiquitination: Pathway activity measure
- Chromosomal breakage: Diagnostic sensitivity assay
- FANCB protein levels: Expression analysis
Prognosis
- FA severity: FANCB mutations generally cause severe phenotype
- Cancer risk: Lifelong monitoring required
- Treatment response: Variable, depends on specific mutation
Research Directions
Current research focuses on:
- Understanding FANCB structure and function
- Developing gene therapy approaches
- FA pathway in neurodegeneration
- Cancer prevention in FA patients
FANCB in Specific Brain Regions
Cerebral Cortex
In cortex:
- DNA repair in neurons
- Age-related dysfunction
- Not well characterized
Hippocampus
In hippocampus:
- Memory circuit DNA repair
- Neural stem cells
- AD links
Substantia Nigra
In substantia nigra:
- Dopaminergic neurons
- PD relevance
- Vulnerability
Cerebellum
In cerebellum:
- Purkinje cells
- Not primary focus
FANCB and Protein Aggregation
Amyloid Pathology
In AD:
- DNA repair capacity
- Accumulated damage
Tau Pathology
In tauopathies:
Alpha-Synuclein
In PD:
FANCB in Glial Cells
Microglial FANCB
- DNA repair in immunity
- Not primary focus
Astrocytic FANCB
Not major players
FANCB and Synaptic Function
DNA Repair at Synapses
Synaptic proteins: Damage accumulation
Repair mechanisms: Not well characterized
Dysfunction: With age/diseaseNot well studied
FANCB in Animal Models
Mouse Models
- Fancb knockout: Embryonic lethal
- Conditional: Tissue-specific
Phenotypic Findings
- DNA repair defects
- Cancer predisposition
FANCB and Cellular Stress
Oxidative Stress
- ROS-induced DNA damage
- FA pathway activation
DNA Damage Response
- ICL repair
- Apoptosis pathways
FANCB as Biomarker
Genetic Testing
- FA diagnosis
- Carrier detection
Not well validated
Therapeutic Strategies
Current Approaches
Challenges
Research Methods
DNA Repair Assays
- ICL repair
- Complementation
Cellular Models
- Patient cells
- Gene editing
Cross-Links
- [FANCD2 Gene](/genes/fancd2)
- [FANCA Gene](/genes/fanca)
- [Fanconi Anemia Pathway](/mechanisms/fanconi-anemia-pathway)
- [DNA Repair](/mechanisms/dna-repair-neurodegeneration)
- [Fanconi Anemia](/diseases/fanconi-anemia)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
See Also
- [DNA Interstrand Crosslink Repair](/mechanisms/icl-repair)
- [FA/BRCA Pathway](/mechanisms/fa-brca-pathway)
- [Genomic Instability in Neurodegeneration](/mechanisms/genomic-instability)
- [Oxidative DNA Damage](/mechanisms/oxidative-dna-damage)
- [DNA Damage Response in Brain](/mechanisms/dna-damage-response-neurodegeneration)
References
[Meetei AR, et al., Identification and functional analysis of FANCB (2004)](https://doi.org/10.1128/MCB.24.13.5852-5860.2004)
[Chandrasekhar D, et al., FANCB and male infertility (2019)](https://doi.org/10.1093/humrep/dey393)
[Vundinti BR, et al., FANCB mutations in Fanconi anemia (2014)](https://doi.org/10.4103/ajts.ajts_45_14)
[Huang Y, et al., X-linked Fanconi anemia (2018)](https://doi.org/10.1093/hmg/ddy136)
[Bogliolo M, et al., The Fanconi anemia core complex (2018)](https://doi.org/10.1016/j.dnarep.2018.03.005)
[Kottemann MC, et al., Fanconi anemia: a paradigm for understanding DNA repair and cancer (2013)](https://doi.org/10.1146/annurev-cancerbio-030117-054437)